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Abstract: Epidemiological studies have reported convincing evidence that natural dietary compounds
may modify inflammation, it being an important event described in the pathophysiology of age-related
infirmity. Among different dietary components, nutritional phenolics have demonstrated links to a
lower risk of inflammation in the most common degenerative and chronic diseases. In this way, the
healthy potential of phenolics against inflammation and the emergence of new functional ingredients
have caused an enhancement of nutraceutical and functional food formulation. The present review
focuses on: (a) nutritional phenolics and their effects on inflammation and (b) functional ingredients
based on phenolic compounds with anti-inflammatory properties. Furthermore, the emerging interest
in health-promoting products by consumers has caused an increase in the demand for functional
products and nutraceuticals. Additionally, this review includes a case study of the Lippia genus,
which has shown anti-inflammatory effects claiming to be a natural alternative for the management
of this physiological disorder. This report is a practical tool for healthcare providers.
Keywords: Lippia; phenolic compounds; anti-inflammatory; pro-inflammatory mediators; cytokines;
prostaglandin; NF-κB
1. Introduction
Inflammation has recently been claimed to be a relevant aspect of the pathophysiology of
age-related ailments and it has been considered an important factor in causing chronic diseases of
industrialized societies, including type 2 diabetes mellitus, cardiovascular disease, Alzheimer’s disease,
and many types of cancer [1]. Inflammations and infection disorders bring with an up-regulation of
different enzymes and signaling proteins in injured tissues and cells. Inflammatory cells are able to
generate and release reactive oxygen species (ROS) and reactive nitrogen species (RNS) such as •O2−
(superoxide anion), •OH (hydroxyl radical), H2O2 (hydrogen peroxide), nitric oxide (NO), and 1O2
(singlet oxygen). The release of ROS and its accumulation in cells may lead the inflammation state.
Among the pro-inflammatory enzymes, nitric oxide synthase (iNOS) and cyclooxygenase (COX), are
the main ones responsible for increasing the levels of nitrogen monoxide (NO) and prostaglandin E2
(PGE2) which are well-known inflammatory compounds related to several chronic diseases.
Natural dietary intake may become an alternative to preventing or alleviating this disorder,
since the intake of natural food contains healthy compounds which seem to play a relevant role in
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inflammation events. For instance, the intake of micronutrients such as magnesium, polyunsaturated
fatty acids (PUFAs), monounsaturated fatty acids (MUFAs) and different groups of phenolics have
demonstrated a decrease in the level of pro-inflammatory markers in serum. Nevertheless, these
pro-inflammatory markers can be increased by an excessive intake of saturated fatty acids (SFA),
trans-fatty acids (TFA) or a high glycemic index carbohydrates [1]. These outcomes have shown the
significant influence of dietary patterns on inflammation processes. In this sense, other studies have
associated the Mediterranean dietary pattern, which is rich in fresh fruit and vegetables, whole grains
and olive oil, with lower levels of pro-inflammatory markers [2].
Among different dietary components, phenolic compounds, including phenolics acids,
hydroxycinnamic acids and flavonoids, including proanthocyanidins, have been shown to be related
to a lowered risk of most common degenerative and chronic diseases. Their antioxidant and
anti-inflammatory activities have been largely attributed to the singular chemical structures [3].
In this sense, medicinal plants have been traditionally used for human health and the evolution of the
understanding of molecular aspects of disorders have led to the establishment of new therapeutic targets
from plants. As an example, the genus Lippia is a perennial plant that belongs to the Verbenaceae family.
This genus, which contains verbascoside as a major phenolic component, has been reported to provide
several potential pharmacological applications which involve inflammatory processes [4]. Recently, the
European Union has listed extracts from plants of the Lippia genus, specifically Lippia citriodora extracts
as new food, enabling its utilization as an ingredient (Commission Implementing Regulation (CIR),
European Union (EU) 2017/2470 of 20 December 2017) and opening up a huge range of possibilities to
healthcare providers.
For this reason, different extraction and isolation procedures have been developed to retrieve
the responsible compounds from natural sources in order to reduce the necessary amounts of food
that provide the desired beneficial effect. Moreover, different encapsulation methods have been
implemented in order to increase the bioavailability of some phenolics with the aim of developing
high value products such as functional foods or nutraceuticals [5,6]. These new products could help to
reduce the prevalence of certain diseases or could even be used as a therapeutic alternative for the
treatment of various ailments.
In this scenario, the aim of this review is to afford a complete overview of the health benefits
associated with phenolic compounds and their anti-inflammatory properties. To achieve this goal,
this project was divided into three different sections: (a) biosynthesis and chemical structure of
phenolics as potential anti-inflammatory molecules; (b) relationship between inflammation and
phenolic compounds, including a report of the main in vitro, in vivo, and clinical trial studies; and (c)
development of phenolic functional ingredient against inflammation, a case study of L. citriodora.
2. Biosynthesis and Chemical Structure of Phenolic Compounds
There are more than 300,000 species of plants documented, which synthesize a large number of
compounds with different purposes. Broadly, these compounds can be divided into two major groups.
On the one hand, the primary metabolites, such as sugars, amino acids or lipid which are necessary for
their development, take part in the photosynthetic and respiratory metabolism of the plant, among
other functions. On the other hand, secondary metabolites are a heterogeneous group of compounds
that are found in specialized cells and they take action in secondary functions such as reproduction,
protecting from predators or ultraviolet radiation, or producing sensory and colorimetric characteristics
in different fruits, vegetables, and flowers [7,8]. In addition to these secondary metabolites being
the focus of many studies in previous decades, especially phenolic compounds, they have also been
shown to possess the ability to improve several physiological functions due to their anti-inflammatory,
antimicrobial, antioxidant or cardioprotective properties [3–6].
Most phenolic compounds are synthesized through different metabolic pathways: pentose
phosphate pathway, malonate/acetate, shikimate, and phenylpropanoid pathways [9,10]. More than
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10,000 different phenolic structures, whose chemical structure consists of at least one aromatic ring
with one or more hydroxyl substituents [9], lead from these pathways.
Moreover, phenolic compounds may build complexes by binding with other substituents. Indeed,
phenolic compounds are naturally present as conjugates with sugar moieties or linked to other phenolic
groups and they may set out functional derivatives as esters or methyl esters [8,11], although it is
also commonly found for them to be associated with organic acids, amines or lipids [9], ranging from
simple molecules as cinnamic acids to highly polymerized substances [12]. Because of the huge variety
of phenolic structures, they are in essence categorized into several classes according to their basic
skeleton. In this sense, structure–activity relationship (SAR) studies have shown that structure and
substitution pattern of hydroxyl groups are essential for effective free radical scavenging activity [13].
The simplest phenolic compounds are phenolic acids which in turn are subdivided into
hydroxybenzoic acids and hydroxycinnamic acids which have C6–C1 and C6–C3 as the particular
carbon skeleton, respectively. Phenolic acids usually are bound with sugars or organic acid and they
are the units of more complex structures as lignins or hydrolysable tannins [14]. For instance, the
union of several gallic acid (a hydroxybenzoic acid) molecules give rise to gallotannins whereas gallic
acid and hexahydroxydiphenoyl (HHDP) moieties are both subunits of the ellagitannins. Moreover,
p-coumaric acid, a hydroxycinnamic acid, is an important precursor to build flavonoids, stilbenoids
and xanthones. These compounds can be found wild in nature or, likewise hydroxybenzoic acids,
bound with sugars or organic acids. In this way, chlorogenic acid also known as caffeoylquinic acid
contains caffeic acid and quinic acid moieties, which are broadly identified in coffee [15]. Moreover,
coumarins emerge from hydroxycinnamic acids by cyclization and ring closure between the hydroxyl
and carboxyl groups [14]. On the other hand, numerous phenolic acids aldehydes are related to the
characteristic aroma of some botanicals and belong to the acetophenones group [16]. In this scenario,
Nile et al. have reported the capacity of ferulic acid related compounds to inhibit tumor necrosis
factor (TNF)-α and interleukin (IL)-6, where gallic acid showed the highest percentage of inhibition in
both parameters. Whereas methyl, propyl, and lauryl gallates reported the lowest anti-inflammatory
activity against TNF-α and IL-6 [17]. This could be due to the methylation of the OH group which
reduces the scavenging activity [18]. In mushrooms, the reduction of NO production was evaluated
in order to study the correlations between phenolic compounds and their anti-inflammatory effects.
Taofiq et al. reported that cinnamic acid showed the highest anti-inflammatory activity presenting
the lowest EC50 values (182 ± 16 µM), followed by p-hydroxybenzoic (239 ± 29 µM) and p-coumaric
(442 ± 33 µM) acids, mainly due to the presence of carboxylic group and no OH groups in the benzene
ring [19].
Flavonoids represent the most widespread and known phenolic group. Indeed, only this group
contains around 8000 structures which are disseminated in many cells and tissues of plants. They
present a basic structure based on three rings building a characteristic C6–C3–C6 skeleton. The wide
range of flavonoid is due to many modifications that suffer in their structures from hydroxylation,
methoxylation or glycosylation and also the linkage of aromatic ring, giving rise to up to thirteen
different subgroups [14]. Some flavonoid structures may bind themselves to form proanthocyanidins
that are considered another phenolic group.
Modification of flavonoids including hydroxylation, o-methylation, and glycosylation, can alter
their metabolic features and affect mechanisms of inflammation. For example, aglycones are more
potent antioxidants than their corresponding glycosides. Specifically, the effective bioactivity of
flavonoids mainly depends on the 3′,4′-orthodihydroxy configuration in ring B and 4-carbonyl group
in ring C. In addition, the presence of a catechol-like structure in ring C and the C2–C3 double bond
configured with a 4-keto arrangement also benefits the antioxidant capacity [20,21]. Quercetin and its
derivatives have been reported to demonstrate a notable concentration-dependent inhibitory potential
towards synthesis of inflammatory mediators [22]. Lesjak et al., pointed out that the number of
free hydroxyl groups of flavonoids is not directly proportional to their anti-inflammatory activity,
specifically their COX-2 inhibition potential [22].
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Tannins are high molecular weight phenolics. Their high weight is associated to their ability to
bind with carbohydrates and proteins. Due to the high variety of structure to get bound, tannins
are divided into three categories: hydrolysable tannins, condensed tannins and a newgroup called
phlorotannins. The phenolics that belong to the first group, gallotannins and ellagitannins, are high
molecular weight molecules with a great antioxidant capacity due to the fact that they can have a
variable number of gallic acid moieties [23]. Condensed tannins arise from the union of many of
these structures achieving a high degree of polymerization (up to 20 moieties or more). Phlorotannins
are polymeric structured, based on the union of many phloroglucinol units and depending on the
linkage, they may be divided into four classes: phlorotannins, fuhalols and phlorethols, fucols and
fucophlorethols, and eckols and carmalols [14].
Finally, lignins are complex structures based on (C6–C3)n that form wood from the plants and
are considered to be the second major substance in plants. They originate from coniferyl alcohol,
p-coumaric alcohol or sinapyl alcohol in a complex polymerization process [14].
3. Inflammation and Phenolic Compounds
Inflammation is now considered to be an important event at the cellular and subcellular level in
diseases. Briefly, this process involves some cells, mainly macrophages, which promote the production
of pro-inflammatory mediators such as interleukins (IL) (IL-1β, IL-6, IL-8); tumor necrosis factor
(TNF)-α, ROS, NO, and prostaglandins (PGs). Their overproduction may be acute or chronic, depending
on two factors: (a) the stimulus and (b) the efficiency of the reaction to remove such stimulus or injured
tissues. A long inflammation state may cause chronic degenerative diseases such as arthritis and
atherosclerosis and it be associated with other diseases such as asthma, Alzheimer’s or cancer [24].
Phenolic compounds are natural antioxidants of the human diet and have a relationship (direct
and indirect) with anti-inflammatory activity helping to alleviate the oxidative stress at the cellular
level [25]. Indeed, dietary phenolics have been related to the modification of the inflammatory cascade
associated with diseases becoming potential targets in the prevention of such conditions [26,27]. In this
sense, some of them act as antioxidants helping to inhibit all the mediators with causes of oxidative
stress such as quercetin or luteolin, other compounds such as kaempferol or hesperidin, acts obstructing
COX-2 decreasing the NO production and consequently alleviating the inflammatory response [28].
Table 1 summarizes the anti-inflammatory action of some dietary compounds.
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Table 1. Modulation of inflammatory response of phenolic compounds tested on in vivo models.
Class Phenolic Compounds Biomarkers Studied Mechanisms Doses Model Reference
Phenolic acids
p-coumaric acid IL-12, TNF-α, and IL-1β
Decreased TNF-α expression
Decreased circulating immune
complexes
100 mg/kg body
weight Adjuvant-induced arthritic rats [29]
Chlorogenic acid NO Decreased the activity of iNOS 5, 20, and 50 mg/kgbody weight LPS-induced acute lung injury rats [30]
Rosmarinic acid TNF-α, Il-1β, and IL-6
Decreased neutrophil activity
Decreased MMP-9 activity
Modulation of NF-κB
10, 25, and 50 mg/kg
body weight Carrageenin-induced paw oedema rat [31]
Ferulic acid iNOS, COX-2, TNF-α, andIL-1β Decreased JNK/NF-κB 20 mg/kg body weight LPS-induced neuroinflammation rats [32]
Verbascoside TNF-α, IL-1β, and IL-6
Decreased IκBα
Decreased NF-κB
Decreased IKK-α
Decreased IKKβ
30 and 60 mg/kg body
weight LPS-induced acute lung injury rats [33]
Flavonol Rutin NOS-2, NF-κB, IkBa, and IL-17
Increased NF-κB
Increased IκBα
phosphorylation
10, 20, and 40 mg/kg
body weight CFZ-induced nephrotoxicity rats [34]
Flavonol Quercetin IL-1β, IL-6, and TNF-α Decreased LPO, NF-κβ, andTNF-α.
10, 20, 25, 40, and 50
mg/kg body weight
Streptozotocin-nicotinamide induced
diabetic rats
Induced inflammation by radiation mice
[35,36]
Flavonol Kaempferol IL-1β, IL-6, TNF-α, MCP-1,and ICAM-1
Decreased HMGB1/TLR4
inflammatory pathway
20 and 50 mg/kg body
weight LPS-induced striatum injury mice [37]
Flavanol Kaempferol-3-O-glucorhamnoside TNF-α, IL-6, IL-1β, and PGE2
Decreased NF-κB and MAP
kinase phosphorylation 50, 100 or 200 µg/kg Klebsiella pneumoniae infected mice [38]
Flavone Luteolin
IL-1β, NO, PGE2, TNF-α, NOS,
COX-2,MMP-1, MMP-2,
MMP-3, MMP-8, and MMP-9
Decreased NF-κB 10 mg/kg body weight MIA-induced osteoarthritis mice [39]
Flavone Luteolin-7-glucoside IL-1β, TNF-α, iNOS, andCOX-2
Decreased NF-κB
Increased PPARγ
Increased Nrf2
20, 40, 80 mg/kg body
weight
Cerebral ischemia-reperfusion induced
neuroinflammation rats [40]
Flavone Acacetin TNF-α, IL-1β Decreased TNF-αIncreased HO-1 50 mg/kg body weight
LPS-induced acute
lung injury rats [41]
Flavan-3-ol Epicatechin TNF-α, iNOS, and IL-6
Decreased TLR4 upregulation
Decreased NOX activation
Decreased NF-kB activation.
80 mg/kg body weight LPS-induced renal inflammation rats [42]
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Table 1. Cont.
Class Phenolic Compounds Biomarkers Studied Mechanisms Doses Model Reference
Flavanol Epigallocatechin gallate TNF-α, IL-1β, IL-6, CINC-3and iNOS
Increased Nrf2
Increased HO-1 40 mg/kg body weight
Fluoride induced lung oxidative
stress rats [43]
Ellagitannin Ellagic acid NO, caspase-3, MMP-9, IL-1β Decreased NF-κB 50 mg/kg body weight FCA-induced arthritis rats [44]
CFZ: Carfilzomib-induced oxidative stress; CINC-3: Cytokine-induced neutrophil chemoattractant; COX-2: Cyclooxygenase-2; FCA: Freund’s complete adjuvant; HMGB1: High mobility
group box 1; HO-1: Heme oxygenase 1; ICAM-1: Intercellular cell adhesion molecule-1; IκBα: Inhibitory kappa-B alpha; IKK-α: Nuclear factor kappa-B kinase-α; IKKβ: Nuclear factor
kappa-B kinase-β; IL: Interleukin; iNOS: Inducible nitric oxide synthase; JNK: c-Jun N-terminal kinases; LPS: Lipopolysaccharide; LPO: Lipid peroxidation; MAP: Mitogen-activated
protein kinase; MCP-1: Monocyte chematotactic protein-1; MIA: Monosodium iodoacetate induced osteoarthritis; MMP-9: Metalloproteinase-9; Nrf2: Increased NF-E2-related factor; NO:
Nitric oxide; PGE2: Prostaglandin E2; PPARγ: Peroxisome proliferator-activated receptor; TLR4: Toll-like receptor 4.
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The latest scientific evidence about in vitro and in vivo effects of the phenolic compounds on their
anti-inflammatory mechanisms have been developed using isolated compounds or crude phenolic
extracts (Figure 1).
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diets compared to BD + DSS. In addition to a reduction in the local inflammatory cytokine profile,
pre-feeding kidney bean diets prior to colitis induction also reduced circulating inflammatory cytokine
levels [50].
Chandran et al., explored the influence of Syzygium calophyllifolium bark methanol extract, enriched
in phenolics, on inflammation as a cancer associated symptom [51]. In this study, a cotton pellet
implanted inflammation model was used to assess the action of the extract in a chronic inflammatory
condition. The results showed that the treated group clearly achieved a decrease in the development of
granulation tissue. Furthermore, the tested dose at 200 mg/kg was found effective against granuloma
formation revealing an inhibition up to 70% compared to the standard drug indomethacin (57%).
These facts demonstrated that S. calophyllifolium bark may be a natural alternative to repress the
migration inflammatory cells, and to prevent irregular permeability of the blood capillaries. In this
way, the chokeberry-concentrate phytochemical profile revealed high content of phenolics including
cyanidin-based anthocyanins, proanthocyanidins, and flavonoids, among others. The outcomes
pointed out that chokeberry concentrate was able to suppress both the release of TNFα, IL-6, and
IL-8 in human peripheral monocytes and to cause the activation of the NF-κB pathway in RAW 264.7
macrophage cells. Additionally, chokeberry showed a synergetic effect with sodium selenite inhibiting
activation of NF-κB, cytokine release, and PGE2 synthesis [52].
Moreover, a great number of clinical trials have been conducted to evaluate the potential of
dietary phenols on anti-inflammatory functions. Indeed, several phenolic supplementations have
been conducted in subjects who have some disorders related to metabolic syndrome, including
obesity [53]. Shi et al., reviewed several studies that reported the potential benefits of blueberry extracts
on inflammatory mediators [54]. Regarding high dietary polyphenol intake from a Mediterranean
diet, a sub study of 1139 high-risk participants was carried out within the PREDIMED trial. After the
intervention with a low-fat diet according to the American Heart Association guidelines, the Med diet
+ extra-virgin olive oil and the Med diet + nuts, participants showed significant changes from base line
values in vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1),
IL-6, TNF-α and MCP-1 concentrations in the three intervention groups. In the covariate analysis
with VCAM-1, ICAM-1, IL-6, TNF-α and MCP-1 concentrations at one year as dependent variables,
circulating VCAM-1, ICAM-1, IL-6, TNF-α and MCP-1 concentrations decreased in both Med diets and
increased in the control diet group [55]. This effect of phenolics has also been investigated in arthritis
models; Oliviero et al., demonstrated the ability for plant-derived natural compounds to modulate the
pro-inflammatory state which characterize the most prevalent arthropathies [56].
Therefore, it is clear that the modulation of inflammatory pathways, mediators, and genes by
ingestion of dietary phenolics plays a relevant role in the prevention, mitigation, and treatment of many
chronic diseases. Nevertheless, it is necessary to know the metabolites produced and the influence
of environmental factors on metabolism in order to determine the impact of phenolics and their
metabolites on health [57]. In this sense, multidisciplinary research has been addressed to develop
phenolic ingredients against inflammation which could be a practical tool for healthcare providers.
Indeed, there are many commercial nutraceuticals attained from different natural sources which have
been tested in induced inflammation models with promising results and some of them are listed in
Table 2 [58].
Table 2. List of available nutraceuticals to manage inflammatory events.
Source Composition Effect Reference
L. citriodora Mainly verbascoside and otherphenylpropanoids
Anti-inflammatory and reducing muscle
damage after sport [58]
Not revealed Phytosterols, RYR,hydroxytyrosol, and vitamin E
Anti-inflammatory in patients
with hypercholesterolemia [59]
Acacia catechu and
Morus alba Catechin, stilbenes, and flavonoids Anti-arthritis effects [60]
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Table 2. Cont.
Source Composition Effect Reference
Olive oil
Oleocanthal, ligstroside aglycone,
docosahexaenoic, and
eicosapentaenoic acids
Anti-osteoarthritis [61]
Chamomile Apigenin, apigenin-7-glucoside,and apigenin-7-(6-acetil)glucoside. Inflammatory in bowel diseases [62]
Pomegranate fruit Mainly ellagic acid Anti-inflammatory in obese patients [63]
Brassica oleracea Anthocyanins Inflammatory in bowel diseases [64]
RYR: red yeast rice.
Among these studies, the genus Lippia has received special attention over the last decade, being
described in the next section.
4. Functional Ingredients based on Phenolic Compounds with Anti-Inflammatory Properties:
Genus Lippia, A Case Study
4.1. Phytochemicals Present in Lippia Plants: Phenolic Compounds and Anti-Inflammatory Properties
The genus Lippia belongs to the Verbenaceae family, where about 250 herbaceous species of shrubs
that may grow to as much as 3 m high, can be found. The most significant number of species grow
in tropical areas of Central and South America and pantropical areas of Africa [65,66]. Nevertheless,
they may also be found in Mediterranean areas [67]. These plants are popular for their characteristic
fragrance. For this reason, species such as Lippia origanoides [68], Lippia dulcis [69] or Lippia alba [70] for
example are commonly used as seasoning in food products.
In addition, some species have been used in traditional medicine to alleviate several ailments,
such as stomach ache, fever, indigestion or joint pains [71–73]. The beneficial properties have been
linked to phytochemicals present in these plants. Their composition and concentrations depend
largely on geographical origin, soil and climate conditions, age, and portion of the plant [74,75].
Overall, phytochemicals present in Lippia plants could be classified in different categories based on
their chemical structures as shown in Table 3 below.
Table 3. Representative phytochemicals found in aerial parts of Lippia genus plants.
Chemical Group Compound Species Reference
Iridoids
Carioptoside Lippia alba [76]
Gardoside L. citriodora [77]
Durandoside I L. citriodora [77]
Hydroxyl campsiside L. citriodora [77]
Ixoside L. citriodora [77]
Lipedoside A I L. citriodora [77]
Lippioside I L. citriodora [77]
Lippioside II L. citriodora [77]
Loganic acid L. alba [76]
Manuleoside H L. citriodora [77]
Myxospyroside L. citriodora [77]
Shanzhiside L. alba [76]
Secologanin L. alba [76]
Secoxyloganin L. alba [76]
teucardoside L. citriodora [77]
Theviridoside Lippia javanica [76]
Theveside L. citriodora [77]
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Table 3. Cont.
Chemical Group Compound Species Reference
Terpenes
Camfor L. citriodora/javanica [78,79]
Caryophyllene L. citriodora/javanica [67,79]
Carvacrol L. citriodora/origanoides [67]
Cimonene L. citriodora [78]
Citral L. citriodora/dulcis [80,81]
Citronelal L. citriodora [5]
Curcumene L. citriodora [82]
Eucalyptol L. javanica [79]
Escualen L. citriodora [5]
Geranial L. citriodora/javanica [67,79]
Geraniol L. citriodora/javanica [67]
Heptacosanol L. citriodora [82]
Ipsdienone L. javanica [79]
Limonene L. citriodora/javanica [79,83]
Linalool L. citriodora/javanica [79,84]
Myrcenone L. citriodora/javanica [79,84]
Neral L. citriodora [5]
Nerol L. citriodora [85]
Nonenal L. citriodora/javanica [67,79]
Sabinene L. citriodora/javanica [78,79]
Spathulenol L. javanica [79]
Thymol L. citriodora/origanoides [83]
α-Terpineol L. citriodora [5]
β-Caryophyllene L. citriodora/dulcis [81,83]
β-Cymene L. citriodora [83]
p-Cymene L. origanoides [81]
γ-Terpinene L. citriodora/javanica [67,79]
Flavonoids
Acacetin-7-diglucuronide L. citriodora [86]
Apigenin L. citriodora/graveolens/javanica [79]
Apigenin-7-diglucuronide L. alba/citriodora [86,87]
Carssifolioside L. javanica [79]
Chrysoeriol L. citriodora/javanica [67,79]
Chrysoeriol-7-diglucuronide L. citriodora [86]
Cirsiliol L. citriodora [67]
Cirsimaritin L. citriodora [67]
Dimethylscutellarein Lippia graveolens [88]
Diosmetin L. citriodora [67]
Eriodictyol L. graveolens [88]
Eriodictyol -7-glucoside L. graveolens [88]
Eupafolin L. citriodora [67]
Eupaforin L. citriodora [67]
Eupatorin L. javanica [79]
Galangin L. graveolens [88]
Genkawin L. javanica [79]
Hipidulin L. citriodora [67]
Hydroxyluteolin L. citriodora/graveolens [88]
Hydroxyluteolin 7-O-hexoside L. graveolens [88]
Hydroxyluteolin 7-O-rhamnoside L. graveolens [88]
Isothymusin L. javanica [79]
Jaceosidin L. citriodora [86]
Luteolin L. citriodora/javanica [67,79]
Luteolin-7-glucoside L. alba/citriodora/graveolens [86–88]
Methylscutellarein L. graveolens [88]
Methoxylutrolin L. javanica [79]
Naringenin L. graveolens [88]
Nepetin L. citriodora [67]
Nepitrin L. citriodora [67]
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Table 3. Cont.
Chemical Group Compound Species Reference
Quercetin L. citriodora/graveolens [67,88]
Pectolinarigenin L. citriodora [67]
Phloretin L. graveolens [88]
Phloretin-6-glucoside L. graveolens [88]
Pinocembrin L. graveolens [88]
Sakuranetin L. graveolens [88]
Salvigenin L. citriodora/javanica [67,79]
Scutellarein L. graveolens [88]
Scutellarein-7-hexoside L. graveolens [88]
Taxifolin L. graveolens [88]
Tricin L. javanica [79]
Phenylpropanoids
Calceolarioside E L. alba [87]
Cistanoside F L. alba/citriodora [86,87]
Decaffeoylverbascoside L. alba [87]
Eukovoside L. citriodora [89]
Hydroxy-verbascoside L. citriodora [89]
Hydroxy-isoverbascoside L. citriodora [89]
Forsythoside A L. citriodora [89]
Forsythoside B L. alba [87]
Isonuomioside L. alba [87]
Isoverbascoside L. citriodora/graveolens/javanica [79]
Lariciresino glucopyranoside L. citriodora [77]
Leucoseptoside L. citriodora [90]
Lippianoside B Lippia tryiphylla [91]
Martynoside L. citriodora [90]
Osmanthisude B L. citriodora [77]
Verbascoside L. citriodora/graveolens/javanica [79,88]
Verbascoside A L. citriodora [77]
Verbascoside L. citriodora [89]
Oxipilins Tuberonic acid glucoside L. citriodora [89]
Different non-phenolic compounds have been described in genus Lippia. Firstly, terpenes and
terpenoids are characterized by their citric flavor and, consequently, they have been broadly used in
several industries [92]. This heterogeneous group belongs to the essential oil fraction and they have been
regarded as an interesting chemical group due to their antimicrobial, insecticide [93], anti-fungal [94],
and anti-malarial properties [95]. A wide range of terpenes and terpenoids have been described in
Lippia and hence divided into monoterpenes and monoterpenoids, sesquiterpens and sesquiterpenoids,
all of which represent volatile compounds. The concentration of these compounds may vary depending
on species [81]. Iridoids are a subgroup of monoterpenoids which are non-volatile compounds. In
general, they present sugar moieties connected to an iridan core giving rise to the derivatives found
in Lippia. Among the iridoids, loganic acid has been found in L. citriodora extracts and revealed to
modulate several metabolic pathways [90]. In addition, several non-phenolic compounds have also
been found which are related to oxipilins chemical groups which are plant hormones synthetized in
stress conditions. In this minority group, derivative compounds of tuberonic acid [89] can be found.
Regarding phenolic compounds, two major groups are found in Lippia species (Figure 2). The
most representative group is phenylpropanoids. This heterogeneous group is characterized by a
phenol bone joined to a three-carbon propene tail. These molecules are primary units of a great
number of polymers such as lignins and they provide ultraviolet light protection or may mediate
pollination [96]. The most representative compound is verbascoside, also known as acteoside. But it
can also be found in different isomers such as isoverbascoside or forsythoside A. All of them are caffeoyl
phenylethanoid glycosides, where caffeic acid and hydroxytyrosol moieties are joined to a rhamnose.
In addition, different verbascoside derivatives were found [89]. These compounds have been shown to
provide hypotensive effects, neuroprotective, antioxidant, and anti-inflammatory effects [71]. This
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phenolic group has been broadly identified in Lippia plants, specifically in L. dulcis, L. multiflora or
L. citriodora [97–99]. Nevertheless, other phenolics belonging to this group have been previously
found in Lippia species. For instance, martynoside, leucoseptoside A, cistanoside F, verbasoside or
campneoside I were also described in L. citriodora [89,90]. Furthermore, calceolarioside E was described
in L. alba to provide anti-oxidant capacity [100].
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On the other hand, the second major group widely studied in Lippia plants is flavonoids.
The phenolic compounds merged into this group may be classified according to their structures. In this
sense, flavones are the most representative in these botanicals. They may be found as 6-hydroxylated,
methoxylated, and glycosylated flavonoids including their aglycone forms. For instance, luteolin may
be found as 6-hydroxyluteolin, luteolin-7-diglucuronide or luteolin in Lippia nodiflora, Lippia canescens
or L. citriodora [90,101]. One of the most abundant flavones is chrysoeriol which, as well as luteolin,
may be found bound to a diglucuronide moiety, known as the most representative flavonoid in
L. citriodora [77]. Additionally, other diglucuronic flavones such as apigenin or acacetin are also
described [89]. Moreover, some flavanones have been characterized in Lippia graveolens such as
naringenin, pinocembrin, and quercetin among others [88,102]. It has been claimed that some of these
compounds possess hepatoprotective effects [103].
The phenolic composition of these plants may be changed according to climatic conditions likewise
season and soil characteristics. Therefore, in a study performed on L. alba, the flavonoid concentration
was higher during summer, whereas phenylpropanoid concentration was higher during winter [75].
Because of this phenolic composition Lippia have been claimed as an alternative to pharmacological
drugs to treat different illnesses.
With regard to biological properties, the main effect of phenolic compounds has been linked to
anti-oxidant and anti-inflammatory effects. In this way, the healthy potential of phenolics from
Lippia and the emergence of new laws in food development have caused an enhancement of
commercialization of diverse functional products based on this plant. For instance, PLX® is a
nutraceutical based on L. citriodora enriched in different concentrations of phenylpropanoids. Several
assays performed on this food supplement have revealed that verbascoside was the most abundant
compound followed by its isomer, isoverbascoside. Moreover, the most representative flavonoid was
chrysoeriol-7-diglucuronide [89,90].
Some compounds of this extract have demonstrated the capacity to modulate several metabolic
pathways related to energetic metabolism such as AMP-activated protein kinase (AMPK), mammalian
target of rapamycin (mTOR) or inflammatory pathways like nuclear factor kappa-light-chain-enhancer
of activated B cells (NF-κB). Indeed, it has been proved that a synergetic effect exists between
phytochemicals contained in Lippia that modulate the expression of NF-κB in hypertrophic adipocytes.
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The level of this transcription factor decreased in the presence of lemon verbena extract. Moreover,
an increase of adiponectin expression was also achieved. Hence, the anti-inflammatory action of
adiponectin together with the decrease of NF-κB and a significant activation of AMPK may cause a
regulation of different markers associated with carbohydrates and lipids metabolism, inflammation,
oxidative stress, and insulin resistance [104].
Further studies demonstrated the individual effects of phytochemical from PLX®, revealing
a significant effect of some iridoids (loganic acid and gardoside) and phenylpropanoids (mostly
verbascoside), which could have a significant impact on AMPK modulation in in vitro assays [90].
In addition, it has also been proven that these compounds inhibit the production of cytokines such
as TNF-α, IL-1β, and IL-6 [105]. These outcomes revealed that L. citriodora may help to prevent or
manage several pathologies typified by disturbances on oxidative and inflammation pathways such as
obesity or cancer.
Moreover, the effects of PLX® have also been tested in in vivo models. Specifically, on rabbits it
has achieved an enhancement of lipid markers decreasing total cholesterol by increasing high density
lipoprotein cholesterol (HDLc) and decreasing low density lipoprotein cholesterol (LDLc), among other
effects. Additionally, the anti-inflammatory properties of L. citriodora caused an improvement in liver
and renal oxidative markers [106]. In a clinical trial, multiple sclerosis patients, where inflammation is
one of the main contributing factors that induces this medical condition, were supplemented with
PLX® capsules in order to evaluate the anti-inflammatory ability of lemon verbena. Results reflected
that L. citriodora extract might affect, depending on the patient clinical subtype, the cytokines profile of
patients preventing or managing the physiological disorders induced by multiple sclerosis [73].
Likewise, an exhaustive exercise may induce oxidative stress and inflammation. This situation
results in an increment of reactive oxygen species causing a disruption of myofibrillar structure and
myofiber necrosis that cause higher muscle fatigue and distress. At this point, the intensity of exercise
decreases whereas muscle recovery time increases, causing a reduction in performance. In this scenario,
Buchwald-Werner et al., tested a new lemon verbena extract called Recoverben® on active people.
The outcomes revealed that 400 mg/day of L. citriodora extract resulted in significantly less muscle
strength loss and an enhancement of muscle recovery after exhaustive exercise [58].
4.2. New Trends in Dietary Phenolics: Functional Ingredients and Nutraceuticals from the Lippia genus
The aging trend of the global population and the increasing incidence of chronic diseases have
resulted in consumer demand for natural foods that may help to delay the onset of these ailments
or improve their symptoms. In recent decades, the consumption of functional foods has soared, so
much so that some ingredients with which they are made, such as phenolics, experienced a growth
rate of 6.1% from 2012 to 2018 [107]. This trend has resulted in governments from all over the world
passing new laws in order to regulate the natural sources whose bioactive compounds could be used
as functional ingredients. Due to the beneficial properties provided by plants from the Lippia genus
and the emerging interest in health-promoting products from consumers, there has been an increase
in the demand for functional products and nutraceuticals. As previously mentioned, the European
Union has listed extracts from plants of the Lippia genus, specifically L. citriodora extracts as a new food
(CIR (EU) 2017/2470 of 20 December 2017), opening up a huge range of possibilities to food industries.
These facts have promoted the optimization of different production processes with the purpose of
retrieving bioactive compounds from natural sources.
The traditional extraction methods that have been applied to the recovery of bioactive compounds
from botanical sources were based on solid–liquid extractions, including maceration, decoctions,
and infusions. These kinds of technological procedures have been applied to industrial production
of nutraceutical and functional ingredients from the Lippia genus. The food industry has addressed
research and production to increase the level of phenolics in Lippia extracts, as well as the bioavailability
in order to increase the biological and health effects.
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Regarding retrieval of phenolics from Lippia, conventional extraction systems have been applied.
Reviewing the literature available, Bilia et al. performed comparative macerations of L. citriodora
and Lippia officinalis leaves. To achieve this goal, four different extractions were developed: two
aqueous decoctions, an aqueous infusion, and an ethanolic maceration. The quantitative analysis
showed that ethanolic maceration had reached a verbascoside yield higher than aqueous infusions and
decoctions. In addition, from the two species analyzed, L. citriodora showed a higher concentration of
verbascoside, and was claimed to be a great source of this bioactive compound [108]. Choupani et al.,
developed four different conventional extractions from L. citriodora leaves based on macerations using
methanol, ethanol, water, and acetone where the extraction yields had values ranging from 3.4% to 10%.
This study showed methanol to be the most efficient solvent to retrieve phenolic compounds [109].
Moreover, similar work has been performed using L. alba as the botanical source. Results displayed
that temperature applied in aqueous extraction could generate the degradation of phenolic compounds.
In addition, ethanolic extracts revealed higher concentrations of phenolic compounds [110].
Advanced extraction systems have increased their applications in the last decade. These
procedures have instigated a technological and economic advance in the food industries, since
they may provide enriched phenolic extracts that, after a drying process, could be used as a powder or
added to food as functional ingredients. In addition, these non-conventional technologies reduce the
environmental impact since they decrease the consumption of solvents, extraction time as well as energy
consumption [111]. Indeed, these non-conventional technologies, also known as green technologies,
have been developed to achieve several common objectives: (1) to extract specific bioactive compounds
from botanicals, (2) to increase the concentration of targeted compounds in functional ingredients,
(3) to improve the selectivity of extraction methods for target bioactive compounds, and (4) to supply a
reproducible method that is independent of botanical source variations [112]. Some of these promising
techniques are pressurized liquid extraction (PLE), supercritical liquid extraction (SFE) or microwave
assisted extraction (MAE), among others. All of them are based on different ways of heat transmission
or penetration inside the sample.
4.2.1. Advanced Extraction Technique for Retrieval of Bioactive Compounds from the Lippia Genus
Thus, PLE is based on the combination of both high temperatures and pressures to achieve a
huge variation in dielectric constant of solvents. These facts succeed in recovering a huge variety of
phytochemicals [111]. This technique has acquired popularity due to the fact that it has proved to
be more efficient in terms of time, amount of solvent and recovery of compounds than traditional
extraction techniques. In addition, great extraction yields have been obtained when PLE has been
applied. In fact, in a comparative study conducted on L. citriodora, PLE was shown to obtain greater
extraction yield than hydro alcoholic macerations as well as phytochemical retrieval. Moreover, it
has been proved to have higher selectivity than conventional extractions, maximizing the recovery of
different chemical groups from L. citriodora leaves by a response surface methodology (RSM) [77].
Another advanced extraction technology that has been revealed to provide higher selectivity
is SFE. This extraction system was applied to recover essential oil as well as phenolics from the
Lippia genus. In comparative studies carried out on L. alba, SFE and several conventional extraction
methods were compared and used to recover essential oils from plant leaves such as hydrodistillation
or simultaneous distillation solvent extraction. These studies revealed that SFE provided a selective
extraction of essential oil fraction from L. alba and it succeeded in recovering a wider range of volatile
compounds than traditional extractions [113]. Moreover, a study conducted by Garmus et al., revealed
that a sequential extraction of SFE, ethanol, and water provided phenolic enriched extracts from
Lippia sidoides with higher antioxidant capacity [114]. These results suggested that SFE could be
an interesting technique for flavor industries since it provides important amounts of essential oils.
Although, SFE has also been shown to be an attractive method to obtain extract with large amounts of
specific phenolic compounds as flavonoids [114].
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Moreover, MAE has been revealed to be an advanced technology which may retrieve thermo
labile compounds from the botanical source. MAE has been coupled with hydrodistillation techniques
in order to retrieve the essential oil fraction from plant leaves. The outcomes revealed that this new
technology provided higher reproducibility while needing less extraction times [74]. Conversely, MAE
has been widely applied to retrieve the phenolic fraction from botanical sources [115,116] providing
excellent results in terms of yield and phenolic profile. Moreover, MAE has been used to recover polar
compounds from L. citriodora by using eutectic solvents, revealing itself to be an interesting alternative
to achieve a selective extraction. These solvents comprise a mix of anionic and cationic species, such as
choline chloride, lactic acid, ethylene glycol or urea. In this study, it might be seen how these kinds
of solvents combined with MAE provided a selective extraction of some phenolics. For instance, the
eutectic solvents formulated with choline chloride and lactic acid enabled a selective extraction of
phenylpropanoids and flavonoids, with verbascoside and chrysoeriol-7-diglucuronide being the most
recovered phenolics and the most promising green tailor-made solvents for retrieval phenolic from
L. citriodora [117].
To establish which extraction system is more suitable, it should be continuously and critically
scrutinized with important criteria, such as high retention capability, high flow rate, problem-free
handling, and being environmentally-friendly, as well as physiological safety. Although several articles
have pointed out the potential application of these advance extraction techniques, the main pilot-plant
and industrial processes include resin chromatography, membrane technologies (filtration and reverse
osmosis) and solid–liquid or liquid–liquid solvent extractions. Choosing the best system for recovering
phenolic compounds from vegetable source may only be done after careful consideration of all the
relevant parameter processes including scale-up. Over the last few years, SFE platforms have been
introduced on an industrial scale as a selective extraction technique to obtain isolated compounds from
vegetable sources. However, PLE and MAE remain on laboratory or pilot-plant level.
4.2.2. Encapsulation Techniques
These obtained extracts which are enriched in phenolic compounds could be used to develop
functional food such as ingredients. Nevertheless, some organoleptic features of phenolic compounds
are not accepted by consumers due to their unpleasant taste. In addition, they have presented low
bioavailability in the gastrointestinal tract. In this sense, it has been estimated that around 5–10%
of the total dietary phenolic are absorbed in the small intestine and from them, aglycones present
higher absorption rates [118]. Additionally, phenolic compounds bioavailability is affected by multiple
factors such as low water solubility, the food matrix, its technological processes or the interactions
produced through the gastrointestinal tract [119]. With the purpose of improving the bioavailability,
bioaccessibility, and undesirable organoleptic aspects of phenolic compounds, several micro and
nano-encapsulation methods have been developed in order to protect the bioactive compounds from
these exogenous factors and to increase their bioavailability by a controlled release in the portion
of gastrointestinal tract where their absorption is maximized as well as to mask any unpleasant
features [120].
The encapsulation consists of creating vesicles or capsules that may range from nanometers to
several millimeters in diameter whose morphology depends on the technological process, the core
and wall materials. The process of manufacturing particles comprises the entrapment of the material
to be encapsulated (core) by wall materials (encapsulating agents) ensuring that undesired materials
are kept out and warranting that the particles are completely closed and avoid leakages [121]. In this
scenario, the most widely used methods to encapsulate phenolic compounds are entrapment with
liposomes, spray drying or freeze drying.
Firstly, the encapsulation with liposomes promote the entrapment of compounds of hydrophilic
and hydrophobic nature at the same time. Although the number of bioactive compounds that may be
loaded in these systems is very low, the bioavailability is profoundly high due to its amphipathic nature
that facilitates the passage of bioactive compounds through the gut barrier. In this sense, liposomes
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are colloidal vesicles formed by a single or multiple lipid bilayer, generally phospholipids, attaining
spherical nanoparticles between 30 nm to several micrometers improving their passage through
intercellular spaces [122]. The characteristic nature of this membranous system allows the entrapment
of several compounds such as protein or phenolic compounds into its aqueous, lipidic, and amphiphilic
spaces [123,124] being usually used in the entrapment of different drugs. Additionally, Mazzacuva et
al. reported that verbascoside obtained from L. alba was encapsulated in complex liposomes combined
with cyclodextrin to improve the permeation of verbascoside through skin. The results showed that
this complex system enabled the verbascoside release in skin [125].
Encapsulation by spray drying is a flexible, continuous, and economic procedure to attain
high quality particles. This technique is not only used in the entrapment of phenolics, but also to
encapsulate several additives and flavors [126]. The result of this process is a homogenous powder
with a size of particle ranging between 10–100 µm [127]. Several polysaccharides have been used as
wall materials to encapsulate polar compounds such as maltodextrins, inulin or alginate [128–130].
Indeed, β-cyclodextrin has been used to encapsulate essential oils from L. graveolens by spray drying,
achieving an encapsulation efficiency of up to 81%. Moreover, these particles succeeded in preserving
de-antimicrobial activity and to improve the antioxidant activity of these essential oils since the wall
material protected essential oils [131].
On the other hand, the freeze-drying principle is based on the thermodynamic properties of water,
getting a result by modifying the surrounding pressure and the sublimation of the water inside the
material near to room temperature. This is a versatile technique which achieves a dehydration of
the material avoiding thermal degradation of the sensitive compounds. Freeze drying is also known
as lyophilization, and the particles obtained present uncertain forms [44]. The biggest drawbacks to
this methodology are the long process times and the low encapsulation efficiency [132]. Although,
reports did not find anything about encapsulation by lyophilization of either phenolics or essential oils
from Lippia, this technique has been revealed as a better encapsulation process to entrap essential oils
from plant rather than spray drying [133]. Another study revealed how freeze-drying encapsulation
succeeded in providing more efficient powder with higher antioxidant capacity than spray drying [134].
Although spray drying has been used to encapsulate essential oils from Lippia, neither freeze drying
nor spray drying have been performed to encapsulate polyphenols from these plants. Nevertheless,
these encapsulation techniques may be an alternative to improve the bioavailability efficiency of
phenolic extracts obtained from L. citriodora and even to apply to current commercial extracts to
implement the bioactivity of phenolics contained in them.
In summary, these extraction and encapsulation systems have opened up a huge variety
of opportunities in functional food development, optimizing the resource utilization and energy
consumption, as well as improving the bioavailability of bioactive compounds obtained from natural
sources. These facts have resulted in botanicals potentially being considered as an interesting alternative
to treat different diseases.
5. Conclusions
Undoubtedly, the beneficial effects of phenolic compounds from natural sources have been broadly
tested. In this sense, several studies have revealed that phenolic compounds have a great potential
modulating ability on pro-inflammatory mediators, giving these phytochemicals a significant role in
the prevention or management of many chronic diseases. Although more studies on the processes
derived from these chronic diseases, such as inflammatory disorders, are necessary, L. citriodora has
been claimed as a natural source of phenolic compounds with anti-inflammatory properties. This
botanical has been used to develop several food supplements (PLX® and Recoverben®) and has been
tested on humans in order to prove the anti-inflammatory or anti-obesogenic effects with interesting
results. On the other hand, the emergence of new extraction technologies may enable the retrieval
of bioactive compounds from botanical sources opening up a new research field in the utilization of
plant-derived phenolics. Additionally, to improve the bioavailability and technological processes of
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phenolic compounds, several microencapsulation strategies have been evaluated. These methodologies
provide some benefits in functional ingredients during functional food formulation. All of these
outcomes could confirm the potential use of L. citriodora as a functional ingredient and its utilization as
an alternative to manage pro-inflammatory states. Nevertheless, this report reflected that more studies
on L. citriodora are needed in order to evaluate the extraction kinetics of phenolic compounds in MAE
and SFE, as well as to ascertain the behavior of these compounds during microencapsulation processes.
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